Massimo Filippi

Sep 3, 2024 | nature.com | Ruth Geraldes |Georgina Arrambide |Alex Rovira |Hans Lassmann |Patrick Waters |Declan T. Chard | +6 more

AbstractMyelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an immune-mediated demyelinating disease that is challenging to differentiate from multiple sclerosis (MS), as the clinical phenotypes overlap, and people with MOGAD can fulfil the current MRI-based diagnostic criteria for MS. In addition, the MOG antibody assays that are an essential component of MOGAD diagnosis are not standardized.

May 15, 2024 | journals.sagepub.com | Paolo Preziosa |Maria A Rocca |Massimo Filippi

Data availability statementData sharing not applicable to this article as no data sets were generated or analyzed during this study. References1. Filippi M, Bar-Or A, Piehl F, et al. Multiple sclerosis. Nat Rev Dis Primers 2018; 4: 43. 2. Chen MH, Cherian C, Elenjickal K, et al. Real-time associations among MS symptoms and cognitive dysfunction using ecological momentary assessment. Front Med (Lausanne) 2022; 9: 1049686. 3. Kasser SL, Goldstein A, Wood PK, et al.

May 15, 2024 | journals.sagepub.com | Paolo Preziosa |Maria A Rocca |Massimo Filippi

Get full access to this articleView all access and purchase options for this article. Data availability statementData sharing not applicable to this article as no data sets were generated or analyzed during this study. References1. Filippi M, Bar-Or A, Piehl F, et al. Multiple sclerosis. Nat Rev Dis Primers 2018; 4: 43. 2. Chen MH, Cherian C, Elenjickal K, et al. Real-time associations among MS symptoms and cognitive dysfunction using ecological momentary assessment.

Feb 6, 2024 | nature.com | Paolo Preziosa |Nicolò Tedone |Massimo Filippi

AbstractIn multiple sclerosis (MS), a non-random and clinically relevant pattern of gray matter (GM) volume loss has been described. Whether differences in regional gene expression might underlay distinctive pathological processes contributing to this regional variability has not been explored yet. Two hundred eighty-six MS patients and 172 healthy controls (HC) underwent a brain 3T MRI, a complete neurological evaluation and a neuropsychological assessment.

Oct 12, 2023 | thelancet.com | Massimo Filippi |Neurorehabilitation Unit |Vita-Salute San Raffaele |Maria A Rocca

Neuroimaging Research Unit, IRCCS San Raffaele Scientific Institute, Milan 20132, ItalyNeurology Unit, IRCCS San Raffaele Scientific Institute, Milan 20132, ItalyNeurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan 20132, ItalyNeurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, ItalyVita-Salute San Raffaele University, Milan, Italy